Intelligence Β· Drug directory

EMA-Approved Drugs Directory

European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

Quick answer

EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.

931 drugs Β· EMA approved Β· by data quality Β· Page 13 of 39

  1. benralizumab

    FASENRA PEN AstraZeneca

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    R03DX10
  2. bezlotoxumab

    ZINPLAVA

    INJECTION FDA: approved Β· EMA: approved

    J06BB21
  3. blinatumomab

    BLINCYTO Amgen

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FX07
  4. brensocatib

    BRINSUPRI

    ORAL FDA: approved Β· EMA: approved

    R03
  5. brinzolamide

    AZOPT Novartis Pharmaceuticals

    OPHTHALMIC FDA: approved Β· EMA: approved Β· TGA: approved

    S01EC04
  6. brodalumab

    KYNTHEUM

    INJECTION FDA: approved Β· EMA: approved Β· PMDA: approved

    L04AC12
  7. cabotegravir

    VOCABRIA ViiV Healthcare Pty Ltd

    INTRAMUSCULAR FDA: approved Β· EMA: approved Β· TGA: approved

    J05AX
  8. caffeine

    PEYONA (PREVIOUSLY NYMUSA)

    RECTAL FDA: approved Β· EMA: approved

    N06BC01
  9. canakinumab

    CANAKINUMAB NOVARTIS

    SUBCUTANEOUS FDA: approved Β· EMA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC08
  10. cangrelor

    KENGREXAL

    INTRAVENOUS FDA: approved Β· EMA: approved

    B01
  11. capivasertib

    TRUQAP AstraZeneca

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01EX27
  12. capsaicin

    QUTENZA

    TOPICAL FDA: approved Β· EMA: approved

    N01BX04
  13. carglumic acid

    CARBAGLU

    ORAL FDA: approved Β· EMA: approved

    A16AA05
  14. cedazuridine

    INAQOVI

    ORAL FDA: approved Β· EMA: approved

    L01BC58
  15. ceftaroline fosamil

    ZINFORO

    INTRAVENOUS FDA: approved Β· EMA: approved

    J01DI02
  16. ceftazidime

    ZAVICEFTA

    INJECTION FDA: approved Β· EMA: approved

    J01DD52
  17. cenobamate

    ONTOZRY

    ORAL FDA: approved Β· EMA: approved

    N03AX
  18. ceritinib

    ZYKADIA Novartis Pharmaceuticals

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved

    L01XE
  19. certolizumab pegol

    CIMZIA

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    L04AB05
  20. cetuximab

    ERBITUX Merck KGaA, Darmstadt, Germany

    INTRAVENOUS FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FE01
  21. choriogonadotropin alfa

    OVIDREL Merck KGaA, Darmstadt, Germany

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    G03GA08
  22. cladribine

    CLADRITAB Merck KGaA, Darmstadt, Germany

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved

    L04AA40
  23. clascoterone

    WINLEVI

    TOPICAL FDA: approved Β· EMA: approved

    D10AX06
  24. cobicistat

    TYBOST

    ORAL FDA: approved Β· EMA: approved

    V03AX03

Frequently asked questions

How many ema approved drugs are listed?

931 drug profiles match this regulatory segment in our published index.

Where does approval data come from?

Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.